This announcement is a separate document:
宁波美诺华药业股份有限公司关于实施2023年度权益分派时“美诺转债”停止转股和转股价格调整的提示性公告
Announcement on the suspension of the conversion of "Menovo Convertible Bonds" and the adjustment of conversion prices in the implementation of equity distribution for the year 2023 by Ningbo Menovo Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.